Drug Profile
Cancer vaccine - Centocor
Latest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Centocor
- Class Cancer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer; Colorectal cancer; Lung cancer; Prostate cancer
Most Recent Events
- 06 Apr 2004 Data presented at the 95th Annual Meeting of the American Association for Cancer Research (AACR-2004) have been added to the Cancer pharmacodynamics section
- 10 Jun 2003 This compound is still in active development
- 10 Jun 2003 Phase-I clinical trials in Colorectal cancer in USA (unspecified route)